MUSTANG BIO, INC.
MB-106, a CAR T-cell immunotherapy for B-cell non-Hodgkin's lymphoma and chronic lymphocytic leukemia
- Sector
- Biotech
- Headquarters
- Worcester, MA
- Founded
- 2015
- Latest Form D
- $2.5M, Jun 2024
- Total capital
- $23.1M
- Federal grants
- $3M
- 2 awards · 2021–2022
- Rank in peer group#333 of 514
- Private capital raised
- $20.1M
- 4 Form D · last Jun 2024
- 28 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$2.5M
- Private capital raisedForm D · SEC · 3rd filing$4.7M
- Federal grantHealth and Human S · Phase II · A Phase 1, Open Label, Multicenter Trial to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients with Relapsed or Refractory CD20+ B-Cell NHL or CLL$999K
- Federal grantHealth and Human S · Phase II · A Phase 1, Open Label, Multicenter Trial to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients with Relapsed or Refractory CD20+ B-Cell NHL or CLL$2M
- Private capital raisedForm D · SEC · 2nd filing$416K
- Private capital raisedForm D · SEC · 1st filing$12.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Adam J. ChillDirectorNamed in SEC Form D filings
- Eliot S. LurierExecutive OfficerNamed in SEC Form D filings
- James B MurphyExecutive OfficerNamed in SEC Form D filings
- Lindsay A. RosenwaldDirectorNamed in SEC Form D filings
- Lindsay A. Rosenwald, M.D.DirectorNamed in SEC Form D filings
- Manuel S. Litchman, M.D.Executive Officer, DirectorNamed in SEC Form D filings
Show all 9 people
- Michael S. WeissExecutive Officer, DirectorNamed in SEC Form D filings
- Michael J. Zelefsky, M.D.DirectorNamed in SEC Form D filings
- Neil A. HerskowitzDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingAnti-idiotype Antibodies And Methods Of Using The SameUSPTOApplication 17191694
- PendingManufacturing Methods For Cell-based Therapeutic CompositionsUSPTOApplication 16375696
- PendingAnti-idiotype Antibodies And Methods Of Using The SameUSPTOApplication PCTUS2021020914
Show all 6 patent records
- Anti-idiotype Antibodies And Methods Of Using The SameSep 9, 2021 · Application 17191694Pending
- Manufacturing Methods For Cell-based Therapeutic CompositionsOct 31, 2019 · Application 16375696Pending
- Anti-idiotype Antibodies And Methods Of Using The SameApplication PCTUS2021020914Pending
- Anti-idiotype Antibodies And Methods Of Using The SameApplication 62986405Pending
- Manufacturing Methods For Cell-based Therapeutic CompositionsApplication PCTUS2019025843Pending
- Manufacturing Methods For Cell-based Therapeutic CompositionsApplication 62654004Pending
Related companies, and why
- ABACUS BIOSCIENCE INCSimilar federal contract value in Biotech · null in contracts
- BIOATLA, LLCSimilar federal contract value in Biotech · null in contracts
- TAMUROBIO INC.Similar federal contract value in Biotech · null in contracts
- UNDERDOG PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- SEMBA BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- Expansion Technologies, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .